Cargando…
LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis
BACKGROUND: Breast cancer (BC) is a prevalent malignancy with complex etiology and varied clinical behavior. Long non-coding RNAs (lncRNAs) have emerged as key regulators in cancer progression, including BC. Among these, lncRNA TDRKH-AS1 has been implicated in several cancers, but its role in BC rem...
Autores principales: | Ding, Yuqin, Huang, Yuting, Zhang, Fanrong, Gong, Lijie, Liang, Chenlu, Ding, Kaijing, He, Xiangming, Ding, Xiaowen, Chen, Yiding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676586/ https://www.ncbi.nlm.nih.gov/pubmed/38008726 http://dx.doi.org/10.1186/s12967-023-04640-3 |
Ejemplares similares
-
The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients
por: Ding, Yuqin, et al.
Publicado: (2023) -
Small extracellular vesicles-transported lncRNA TDRKH-AS1 derived from AOPPs-treated trophoblasts initiates endothelial cells pyroptosis through PDIA4/DDIT4 axis in preeclampsia
por: Chen, Qian, et al.
Publicado: (2023) -
Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients
por: Ding, Yuqin, et al.
Publicado: (2020) -
A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
por: Ni, Wen, et al.
Publicado: (2017) -
Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
por: Ni, Wen, et al.
Publicado: (2023)